Oligonucleotide Delivery to the Lung: Waiting to Inhale

Oligonucleotide Delivery to the Lung: Waiting to Inhale

Bibliographic Details
Main Authors:	Jørgen Kjems, Kenneth A Howard
Format:	Article
Language:	English
Published:	Elsevier 2012-01-01
Series:	Molecular Therapy: Nucleic Acids
Online Access:	http://www.sciencedirect.com/science/article/pii/S2162253116300609

Similar Items

Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites
by: Berkhout Ben, et al.
Published: (2007-04-01)

RNA nanostructures for targeted drug delivery and imaging
by: Laura Teodori, et al.
Published: (2024-12-01)

Advances in oligonucleotide drug delivery
by: Roberts, TC, et al.
Published: (2020)

Delivery of therapeutic oligonucleotides in nanoscale
by: Lei Wu, et al.
Published: (2022-01-01)

Nanocarriers for Delivery of Oligonucleotides to the CNS
by: David Male, et al.
Published: (2022-01-01)

Advances in oligonucleotide drug delivery
by: Roberts, Thomas C, et al.
Published: (2021)

Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis
by: Xiaoxuan Han, et al.
Published: (2023-05-01)

Delivery of RNAi-Based Oligonucleotides by Electropermeabilization
by: Muriel Golzio, et al.
Published: (2013-04-01)

Light-Triggered Cellular Delivery of Oligonucleotides
by: Leena-Stiina Kontturi, et al.
Published: (2019-02-01)

Peptide conjugation to enhance oligonucleotide delivery
by: Wolfe, Justin Mahoney
Published: (2018)

Aptamer-Targeted Drug Delivery for Staphylococcus aureus Biofilm
by: Pernille Ommen, et al.
Published: (2022-04-01)

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
by: Hammond, SM, et al.
Published: (2021)

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
by: Suzan M Hammond, et al.
Published: (2021-04-01)

Nonviral delivery systems for antisense oligonucleotide therapeutics
by: Si Huang, et al.
Published: (2022-09-01)

The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
by: Maria Gagliardi, et al.
Published: (2021-04-01)

An Albumin-Oligonucleotide Assembly for Potential Combinatorial Drug Delivery and Half-Life Extension Applications
by: Matthias Kuhlmann, et al.
Published: (2017-12-01)

Waiting to inhale: factors associated with healthcare workers’ fears of occupationally-acquired tuberculosis (TB)
by: Michelle Engelbrecht, et al.
Published: (2019-05-01)

Inhaled drug delivery: a randomized study in intubated patients with healthy lungs
by: Jonathan Dugernier, et al.
Published: (2023-12-01)

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
by: Helena Gauani, et al.
Published: (2023-03-01)

Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
by: Haneen Daralnakhla, et al.
Published: (2021-01-01)

Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
by: Phuc Tran, et al.
Published: (2022-02-01)

Delivery of Gold Nanoparticles Inside Carbon Nanotubes by Oligonucleotides
by: Daxiang Cui, et al.
Published: (2011-12-01)

Nano and Microtechnologies for the Delivery of Oligonucleotides with Gene Silencing Properties
by: Giuseppe De Rosa, et al.
Published: (2009-07-01)

Potential Of Antisense Oligonucleotides (ASO) Through Inhalation Based On Gold Nanoparticle (AuNP) Delivery System In Inhibiting SARS-CoV-2 Replication And Transcription
by: Raehan Satya Deanasa, et al.
Published: (2022-09-01)

Plasmid Inhalation: Delivery to the Airways
by: Davies, L, et al.
Published: (2006)

Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model
by: Philip J. Kuehl, et al.
Published: (2018-01-01)

Cell-penetrating peptides to enhance delivery of Oligonucleotide-based therapeutics
by: McClorey, G, et al.
Published: (2018)

Chemical Manipulation of the Endosome Trafficking Machinery: Implications for Oligonucleotide Delivery
by: Rudolph L. Juliano
Published: (2021-05-01)

Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin
by: Monique C. P. Mendonça, et al.
Published: (2023-02-01)

Perfluoroaryl Bicyclic Cell-Penetrating Peptides for Delivery of Antisense Oligonucleotides
by: Wolfe, Justin, et al.
Published: (2020)

DNA/RNA heteroduplex oligonucleotides: An unanticipated twist in the delivery of ASOs
by: Ryan L. Setten, et al.
Published: (2022-09-01)

Improving Cardiac Delivery of Antisense Oligonucleotides with Peptidomimetic Targeting Agents
by: Antilla, Sarah An-ning
Published: (2023)

Nanocarriers for inhaled delivery of RNA therapeutics
by: Sebastian G. Huayamares, et al.
Published: (2024-01-01)

Delivery of theophylline as dry powder for inhalation
by: Bing Zhu, et al.
Published: (2015-12-01)

Transport Oligonucleotides—A Novel System for Intracellular Delivery of Antisense Therapeutics
by: Oleg V. Markov, et al.
Published: (2020-08-01)

Patophysiology of the lung inhalation injuries
by: Vulović Tatjana, et al.
Published: (2007-01-01)

Functionalizing Fibrin Hydrogels with Thermally Responsive Oligonucleotide Tethers for On-Demand Delivery
by: Chase S. Linsley, et al.
Published: (2022-01-01)

Biophysical model to predict lung delivery from a dual bronchodilator dry-powder inhaler
by: Myrna B. Dolovich, et al.
Published: (2019-12-01)

Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA
by: Peter Järver, et al.
Published: (2012-01-01)

Peptide-mediated cell and in vivo delivery of antisense oligonucleotides and siRNA
by: Järver, P, et al.
Published: (2012)